首页 > 期刊杂志 > 正文

Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).

卵巢、输卵管以及原发性腹膜癌报告数据集:国际癌症报告合作组织(ICCR)建议

McCluggage WG,Judge MJ,Clarke BA,Davidson B,Gilks CB,Hollema H,Ledermann JA,Matias-Guiu X,Mikami Y,Stewart CJ,Vang R,Hirschowitz L
阅读:537 Modern PathologyAug 2015; 28 (8): 1012 - 1149:1101-1122 

Abstract

A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but these vary in their content. The International Collaboration on Cancer Reporting (ICCR) is an alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer and the European Society of Pathology, with the aim of developing an evidence-based reporting data set for each cancer site. This will reduce the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish and maintain standardised cancer reporting data sets. The resultant standardisation of cancer reporting will benefit not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets. We describe the development of a cancer data set by the ICCR expert panel for the reporting of primary ovarian, fallopian tube and peritoneal carcinoma and present the 'required' and 'recommended' elements to be included in the report with an explanatory commentary. This data set encompasses the recent International Federation of Obstetricians and Gynaecologists staging system for these neoplasms and the updated World Health Organisation Classification of Tumours of the Female Reproductive Organs. The data set also addresses issues about site assignment of the primary tumour in high-grade serous carcinomas and proposes a scoring system for the assessment of tumour response to neoadjuvant chemotherapy. The widespread implementation of this data set will facilitate consistent and accurate data collection, comparison of epidemiological and pathological parameters between different populations, facilitate research and hopefully will result in improved patient management.

摘要

一份完善的病理学报告对于患者的合理治疗、癌症分期以及预后至关重要。许多国家采用格式化报告,但是它们的内容有所变化。国际癌症报告合作组织(ICCR)是由澳大利亚皇家病理医师学会、英国皇家病理医师学会、美国病理医师学会、加拿大抗癌合作组织以及欧洲病理学会组成的联盟,旨在建立一个针对各种癌症有据可依的报告数据集。这将减轻全球建立癌症数据集的负担以及各种国际机构委托、公布和维持标准化癌症报告数据集所做的重复工作。癌症报告结果的标准化不仅有利于那些直接参与合作的国家,同时也有利于其他未参与国家建立它们自己的数据集。我们描述了ICCR专家小组针对原发性卵巢、输卵管以及腹膜癌报告所建立的癌症数据集,提出在报告中要包含“需要”和“推荐”的要素并作解释说明。这一数据集包括国际妇产科联盟关于这些肿瘤的最新分期系统以及世界卫生组织最新女性生殖器官肿瘤分类。数据集也叙述了关于原发性肿瘤中高级别浆液性癌的位置分布问题,同时也提出了一个评估肿瘤对新辅助化疗反应的评分系统。这一数据集的广泛执行将有利于一致的、准确的数据收集、不同群体间流行病学和病理学参数的比较,有利于研究,并且有希望改善患者的治疗。
full text

我要评论

0条评论